- Home
- PHAR vs TECX Comparison
PHAR vs TECX Comparison
Compare PHAR & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- TECX
- Stock Information
- Founded
- PHAR 1988
- TECX 2019
- Country
- PHAR Netherlands
- TECX United States
- Employees
- PHAR N/A
- TECX N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- TECX
- Sector
- PHAR Health Care
- TECX
- Exchange
- PHAR Nasdaq
- TECX Nasdaq
- Market Cap
- PHAR 627.5M
- TECX 647.7M
- IPO Year
- PHAR N/A
- TECX 2018
- Fundamental
- Price
- PHAR $9.98
- TECX $40.90
- Analyst Decision
- PHAR Strong Buy
- TECX Strong Buy
- Analyst Count
- PHAR 3
- TECX 5
- Target Price
- PHAR $27.00
- TECX $72.25
- AVG Volume (30 Days)
- PHAR 6.0K
- TECX 118.2K
- Earning Date
- PHAR 03-13-2025
- TECX 02-24-2025
- Dividend Yield
- PHAR N/A
- TECX N/A
- EPS Growth
- PHAR N/A
- TECX N/A
- EPS
- PHAR N/A
- TECX N/A
- Revenue
- PHAR $285,745,000.00
- TECX N/A
- Revenue This Year
- PHAR $20.08
- TECX N/A
- Revenue Next Year
- PHAR $9.22
- TECX N/A
- P/E Ratio
- PHAR N/A
- TECX N/A
- Revenue Growth
- PHAR 30.64
- TECX N/A
- 52 Week Low
- PHAR $6.65
- TECX $1.40
- 52 Week High
- PHAR $13.20
- TECX $53.41
- Technical
- Relative Strength Index (RSI)
- PHAR 56.13
- TECX 42.12
- Support Level
- PHAR $9.37
- TECX $37.07
- Resistance Level
- PHAR $10.15
- TECX $50.09
- Average True Range (ATR)
- PHAR 0.50
- TECX 3.22
- MACD
- PHAR -0.09
- TECX -0.72
- Stochastic Oscillator
- PHAR 57.53
- TECX 26.07
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.